Search - tctmd.com

Displaying 841 - 860 of 1267

Sort: Relevancy | Date

News Daily News

Walk and Talk: Step-Counting Devices Work Best When Paired With Doctor Consults

Yael L. Maxwell

October 10, 2019

News Daily News

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Shelley Wood

October 08, 2019

News Conference News

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

Michael O'Riordan

October 07, 2019

News Daily News

Interventional Options and Future Directions for Acute PE: New AHA Statement

Todd Neale

October 07, 2019

Presentation TCT 2019

Experience on the Early Feasibility Study (US Industry’s View)

Presenter: Robert Thatcher

September 26, 2019

Presentation TCT 2019

Experience on the Global Clinical Trial (Japanese Industry’s View)

Presenter: Daiki Yasuhara

September 26, 2019

Presentation TCT 2019

The Basic Regulation Pathway For an Early Feasibility Study in the US

Presenter: Hiren Mistry

September 26, 2019

Presentation TCT 2019

The Basic Regulation Pathway For a Clinical Trial in Japan Compared to US Regulation

Presenter: Mitsuru Yuba

September 26, 2019

News Opinion Fellow Talk

What I Am Most Looking Forward to at TCT 2019

Mahesh V. Madhavan, MD

September 18, 2019

News Conference News HFSA 2019

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

L.A. McKeown

September 18, 2019

News Conference News HFSA 2019

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

L.A. McKeown

September 16, 2019

News CV Team Pro

The Providence St. Vincent Medical Center Cath Lab Team

L.A. McKeown

September 12, 2019

News Conference News ESC 2019

Community-Level Salt-Swapping Strategy Pays Dividends in Peru

Todd Neale

September 09, 2019

News Conference News ESC 2019

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

L.A. McKeown

September 09, 2019

News Conference News ESC 2019

Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories

Yael L. Maxwell

September 06, 2019

News Conference News ESC 2019

ESC Updates Guidance on Management of Acute Pulmonary Embolism

Todd Neale

September 06, 2019

News Conference News ESC 2019

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

Michael O'Riordan

September 05, 2019

News Conference News ESC 2019

Lifelong Exposure to Lower LDL and BP Linked With Big Reduction in CVD Events

Michael O'Riordan

September 02, 2019

News Conference News ESC 2019

CONDI-2/ERIC-PPCI Puts the Kibosh on Ischemic Conditioning in STEMI

Yael L. Maxwell

September 01, 2019

News Conference News ESC 2019

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

Yael L. Maxwell

September 01, 2019

Advertisement

Walk and Talk: Step-Counting Devices Work Best When Paired With Doctor Consults

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

Interventional Options and Future Directions for Acute PE: New AHA Statement

Experience on the Early Feasibility Study (US Industry’s View)

Experience on the Global Clinical Trial (Japanese Industry’s View)

The Basic Regulation Pathway For an Early Feasibility Study in the US

The Basic Regulation Pathway For a Clinical Trial in Japan Compared to US Regulation

What I Am Most Looking Forward to at TCT 2019

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

The Providence St. Vincent Medical Center Cath Lab Team

Community-Level Salt-Swapping Strategy Pays Dividends in Peru

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories

ESC Updates Guidance on Management of Acute Pulmonary Embolism

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

Lifelong Exposure to Lower LDL and BP Linked With Big Reduction in CVD Events

CONDI-2/ERIC-PPCI Puts the Kibosh on Ischemic Conditioning in STEMI

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content